Oxford Nanopore Technologies PLC at Barclays Global Healthcare Conference Transcript
Good morning. My name is Blanka Porkolab, and I sit within the European MedTech and services research team at Barclays. I'm very fortunate to have with me today Gordon Sanghera, CEO; and Nick Keher, CFO at Oxford Nanopore Technologies.
Thank you both for joining us today and a warm welcome to those in the room and those that have joined us online.
Questions & Answers
Jumping straight into Q&A and starting with the group's outlook, how much of the top end of this year's sales outlook is dependent on these larger project wins that you spoke about at results last week? Could you get into the top end without any large wins?
Nick, would you like to --
Yeah, of course. So important thing to recognize with the guidance that we've given is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
